Critical Mass

Overview

Critical Mass is an indica-dominant hybrid most often credited to Shantibaba's Mr. Nice Seedbank, who describes it as a reworking of an older Big Bud line crossed with Skunk #1 ^[1]. It became popular in European seed catalogs in the early 2000s and remains a staple in commercial and home gardens because of one trait above all others: yield. Buds are exceptionally dense and heavy, often to the point that lower branches need physical support during late flower Anecdote.

The name 'Critical Mass' is now used by multiple seed companies for genetics that may or may not trace back to the Mr. Nice line, and a separate CBD-rich version (sometimes labeled 'Critical Mass CBD' or 'CBD Critical Mass') is offered by breeders such as Dinafem and CBD Crew ^[2]. Treat the name as a category, not a guarantee of identical genetics.

Chemistry

Cannabinoids. Standard Critical Mass typically tests in the 19–22% THC range with negligible CBD, based on commercial lab data and seedbank-reported figures ^[1][2]. CBD-rich phenotypes marketed under the same name commonly report roughly 1:1 THC:CBD ratios, with both cannabinoids in the 5–8% range ^[2]. Individual plant chemistry varies substantially with phenotype, cultivation, and harvest timing — strain-name THC averages should be read as ballpark, not specification Strong evidence^[3].

Terpenes. Published terpene profiling of cultivars sold as Critical Mass is sparse in peer-reviewed literature. Available commercial COAs and aggregated lab datasets consistently list myrcene as the dominant terpene, with secondary contributions from caryophyllene and pinene Weak / limited^[4]. This is a common myrcene-dominant profile shared with many indica-labeled cultivars.

A note on folklore: the often-repeated claim that 'myrcene above 0.5% makes a strain sedating / indica' is not supported by controlled human research. It originated in popular cannabis writing and has been repeated until it sounds like fact Disputed^[5].

Reported effects

There is no strain-specific clinical research on Critical Mass. Everything below is aggregated user reporting from consumer platforms and seedbank descriptions, which are subject to expectancy effects, selection bias, and marketing influence Anecdote.

Commonly reported effects:

• Strong physical relaxation, heaviness in the limbs ('couch-lock')
• Sedation, drowsiness — frequently used as an evening strain
• Appetite stimulation
• Mild euphoria early, fading into sleepiness

Users report it for muscle tension, insomnia, and appetite loss Anecdote. These reports are consistent with what's known about THC pharmacology generally — but they are not evidence that this specific cultivar outperforms others for those uses. The 'indica = sedating, sativa = energizing' framework that drives most strain marketing has been repeatedly challenged in chemotaxonomic studies, which find that indica/sativa labels poorly predict chemistry or effect Strong evidence^[6].

Lineage

The widely cited lineage is Big Bud × Skunk #1, as documented by Mr. Nice Seedbank ^[1]. Shantibaba has stated the line was developed to recover and stabilize the yield traits of older Big Bud stock he worked with in the 1990s.

Caveats:

• 'Big Bud' itself has a murky history, with multiple unrelated cuts circulating under the name since the 1980s Disputed.
• Many seed companies sell a 'Critical Mass' that is not from the Mr. Nice line. These may be independent crosses selected for similar phenotype, S1s of unknown clones, or rebranded stock. Without genetic testing (e.g., via services like Phylos), claims of identity cannot be verified Weak / limited.
• The CBD-dominant 'Critical Mass CBD' line is a separate breeding project that crossed a Critical Mass parent with a CBD-rich donor (commonly cited as a Cannatonic-derived line) ^[2].

Treat any specific lineage claim on a seed packet as a marketing assertion unless backed by genotype data.

Cultivation basics

Critical Mass is popular with growers because it finishes fast and yields heavily, but those same traits create the main cultivation problem.

Flowering time: ~7–8 weeks indoors; outdoor harvest in the Northern Hemisphere typically falls in mid- to late September ^[1].

Yield: Reported indoor yields commonly land in the 500–600 g/m² range under competent cultivation, with outdoor plants capable of producing well over 600 g per plant in favorable conditions ^[1]. These are breeder/grower figures, not independently audited.

Structure: Short to medium height, with thick main colas and dense internodal flower clusters. Branches often need staking or netting in late flower.

**Key risk — bud rot (Botrytis cinerea):** The dense bud structure traps humidity inside the flower, making Critical Mass notoriously susceptible to gray mold, particularly in late flower and in humid environments Strong evidence^[7]. Practical mitigations: aggressive dehumidification (keep RH below ~55% in late flower), strong airflow through the canopy, defoliation to open up the plant, and an early harvest if rot is detected.

Difficulty: Easy to grow, harder to grow well. New growers often produce big plants and then lose 20–40% of the harvest to rot in the final two weeks.

Marketing vs. reality

Claim: 'Critical Mass is one of the highest-yielding strains in the world.' Reality: It is genuinely high-yielding for an indoor commercial cultivar, and that reputation is earned. But 'highest in the world' is a marketing flourish — many modern hybrids match or exceed it under optimized conditions Weak / limited.

Claim: 'Heavy indica — guaranteed couch-lock.' Reality: Effect depends on dose, individual physiology, tolerance, set/setting, and the specific chemotype you're holding. Indica labeling does not reliably predict outcome Strong evidence^[6].

Claim: 'Critical Mass CBD = the medical version.' Reality: A higher-CBD chemovar is a legitimate option for users who want less intoxication, but 'medical' is a regulatory and clinical designation, not a strain property. Strain-specific medical claims do not have clinical trial support No data.

Claim: 'Same genetics across every seedbank selling Critical Mass.' Reality: Almost certainly not. Without genotype data, assume each vendor's 'Critical Mass' is its own line Disputed.

Sources

How this page was made

Related

• Big Bud — A heavy-yielding indica-leaning strain prized by commercial growers for sheer weight rathe...
• Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...
• Skunk #1 — The foundational hybrid that defined modern cannabis breeding and gave the world a new voc...